First Header Logo Second Header Logo

Gregory Kucera

Concepts (185)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
22
2017
611
1.540
Why?
Platinum
11
2014
21
1.100
Why?
Acridines
13
2014
19
1.090
Why?
Deoxycytidine
3
2017
68
0.620
Why?
Organoplatinum Compounds
5
2014
47
0.440
Why?
Thiourea
5
2015
5
0.430
Why?
Neoplasms
4
2019
695
0.400
Why?
Cell Line, Tumor
18
2020
736
0.400
Why?
Nucleosides
2
2016
10
0.390
Why?
Prodrugs
2
2014
16
0.380
Why?
DNA
7
2014
229
0.380
Why?
Drug Design
8
2014
47
0.360
Why?
Intercalating Agents
5
2014
9
0.360
Why?
Lipids
2
2016
226
0.350
Why?
Ovarian Neoplasms
2
2007
95
0.330
Why?
Drug Screening Assays, Antitumor
12
2017
58
0.310
Why?
Drug Resistance, Neoplasm
3
2017
105
0.290
Why?
Hyperthermia, Induced
2
2007
246
0.290
Why?
Nitrobenzenes
1
2006
10
0.290
Why?
Cyclooxygenase 2 Inhibitors
1
2006
15
0.280
Why?
HL-60 Cells
5
2008
14
0.280
Why?
Sulfonamides
1
2006
67
0.270
Why?
DNA Damage
4
2017
100
0.270
Why?
Cytarabine
2
2017
55
0.260
Why?
Antimetabolites, Antineoplastic
1
2005
49
0.250
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2017
462
0.240
Why?
Phosphatidic Acids
1
2003
1
0.230
Why?
Apoptosis
4
2017
368
0.230
Why?
Coordination Complexes
2
2015
9
0.220
Why?
Gold
2
2015
18
0.220
Why?
Humans
31
2020
32297
0.210
Why?
Anisomycin
1
2002
3
0.210
Why?
Protein Synthesis Inhibitors
1
2002
11
0.210
Why?
Mitoxantrone
1
2002
19
0.200
Why?
Mitogen-Activated Protein Kinases
1
2002
37
0.200
Why?
Structure-Activity Relationship
10
2014
83
0.200
Why?
DNA Adducts
5
2014
13
0.190
Why?
Citric Acid Cycle
1
2020
11
0.190
Why?
Pyruvate Dehydrogenase Complex
1
2020
18
0.190
Why?
DNA, Neoplasm
3
2013
56
0.180
Why?
Urea
3
2009
39
0.180
Why?
AMP-Activated Protein Kinases
1
2020
38
0.180
Why?
Tissue Array Analysis
1
2019
34
0.170
Why?
Lung Neoplasms
4
2014
409
0.170
Why?
Myeloid Cells
1
2019
40
0.160
Why?
Adenine
2
2010
15
0.160
Why?
Cell Proliferation
4
2015
602
0.150
Why?
Glycerophosphates
1
2017
4
0.150
Why?
Tumor Cells, Cultured
3
2006
171
0.140
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
44
0.140
Why?
Solubility
3
2008
38
0.140
Why?
Breast Neoplasms
2
2020
759
0.130
Why?
Prodigiosin
2
2006
2
0.120
Why?
Protein Kinase Inhibitors
1
2015
85
0.120
Why?
Cell Cycle
1
2014
78
0.110
Why?
Cisplatin
3
2012
77
0.110
Why?
Antineoplastic Agents, Hormonal
1
2013
40
0.110
Why?
Inhibitory Concentration 50
3
2015
23
0.110
Why?
Microscopy, Confocal
1
2013
67
0.110
Why?
Tamoxifen
1
2013
56
0.110
Why?
Drug Delivery Systems
1
2014
101
0.110
Why?
Fluorescent Dyes
1
2013
49
0.110
Why?
Carboxylic Acids
1
2012
2
0.110
Why?
Small Molecule Libraries
1
2012
11
0.110
Why?
Dose-Response Relationship, Drug
5
2017
675
0.100
Why?
Chelating Agents
2
2009
17
0.100
Why?
Animals
7
2020
7694
0.100
Why?
Spectrometry, Mass, Electrospray Ionization
4
2012
34
0.100
Why?
Chromatography, High Pressure Liquid
4
2012
96
0.100
Why?
Cell Survival
3
2020
301
0.090
Why?
Alkylating Agents
1
2010
5
0.090
Why?
Organogold Compounds
1
2009
4
0.090
Why?
Mycobacterium tuberculosis
1
2009
7
0.090
Why?
Antitubercular Agents
1
2009
7
0.090
Why?
Platinum Compounds
1
2009
3
0.090
Why?
2,2'-Dipyridyl
1
2009
3
0.090
Why?
Cell Line
2
2015
462
0.080
Why?
Guanidine
1
2008
3
0.080
Why?
Combined Modality Therapy
2
2007
567
0.080
Why?
Carboplatin
1
2007
48
0.070
Why?
Alkaloids
1
2006
9
0.070
Why?
Dinoprostone
1
2006
34
0.070
Why?
Drug Synergism
1
2006
71
0.070
Why?
Cyclooxygenase 2
1
2006
46
0.070
Why?
Taxoids
1
2006
59
0.070
Why?
Signal Transduction
2
2020
701
0.070
Why?
Deoxycytidine Kinase
1
2005
2
0.060
Why?
Phospholipids
1
2005
28
0.060
Why?
Mice, Nude
2
2020
298
0.060
Why?
Enzyme Activation
2
2020
135
0.060
Why?
Monoterpenes
1
2004
3
0.060
Why?
Genes, Neoplasm
1
2004
18
0.060
Why?
Stereoisomerism
3
2008
24
0.060
Why?
Buffers
1
2003
9
0.060
Why?
Ribonucleotide Reductases
1
2003
6
0.060
Why?
Biological Availability
2
2016
22
0.060
Why?
Rhodium
1
2002
1
0.060
Why?
Organometallic Compounds
1
2002
25
0.050
Why?
Models, Molecular
3
2008
197
0.050
Why?
Female
5
2020
20126
0.050
Why?
Precipitin Tests
1
2002
14
0.050
Why?
JNK Mitogen-Activated Protein Kinases
1
2002
14
0.050
Why?
Flavonoids
1
2002
18
0.050
Why?
Leukemia, Myeloid
1
2002
24
0.050
Why?
Mitogen-Activated Protein Kinase 3
1
2002
44
0.050
Why?
p38 Mitogen-Activated Protein Kinases
1
2002
37
0.050
Why?
Pyridines
1
2002
81
0.050
Why?
Imidazoles
1
2002
97
0.050
Why?
Transfection
1
2002
202
0.050
Why?
Blotting, Western
1
2002
305
0.050
Why?
Phosphoserine
1
2020
8
0.050
Why?
Mice
3
2014
2524
0.050
Why?
Catalytic Domain
1
2020
65
0.050
Why?
Water
2
2012
57
0.050
Why?
Stress, Physiological
1
2020
55
0.050
Why?
Mice, Inbred BALB C
1
2020
171
0.050
Why?
Phosphorylation
1
2020
234
0.040
Why?
Tissue Fixation
1
2019
10
0.040
Why?
Paraffin Embedding
1
2019
10
0.040
Why?
Neoplasm Metastasis
1
2020
222
0.040
Why?
Formaldehyde
1
2019
11
0.040
Why?
Survival Analysis
1
2020
491
0.040
Why?
Crystallography, X-Ray
2
2009
92
0.040
Why?
Philadelphia Chromosome
1
2017
4
0.040
Why?
Protein Kinase C
1
2017
32
0.040
Why?
Tumor Burden
1
2017
61
0.040
Why?
Neoplasm Transplantation
1
2017
75
0.040
Why?
Doxorubicin
1
2017
79
0.040
Why?
Random Allocation
1
2017
220
0.040
Why?
Mice, Transgenic
1
2017
261
0.030
Why?
Molecular Structure
2
2008
60
0.030
Why?
Photochemistry
2
2006
6
0.030
Why?
Quinazolines
1
2015
38
0.030
Why?
G-Quadruplexes
1
2014
8
0.030
Why?
Valproic Acid
1
2014
14
0.030
Why?
Hydrolysis
1
2014
41
0.030
Why?
Mice, Inbred C57BL
1
2017
773
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2014
101
0.030
Why?
Flow Cytometry
1
2014
187
0.030
Why?
Hydrazines
1
2013
4
0.030
Why?
Carcinoma, Squamous Cell
1
2014
154
0.030
Why?
Receptors, Estrogen
1
2013
103
0.030
Why?
Esters
1
2012
10
0.030
Why?
Chromatography, Reverse-Phase
1
2012
1
0.030
Why?
Cell-Free System
1
2012
15
0.030
Why?
Adenocarcinoma
1
2014
315
0.020
Why?
DNA Cleavage
1
2010
4
0.020
Why?
Netropsin
1
2010
3
0.020
Why?
Vero Cells
1
2009
4
0.020
Why?
DNA, Bacterial
1
2009
21
0.020
Why?
Ligands
1
2009
89
0.020
Why?
Chemistry, Pharmaceutical
1
2008
11
0.020
Why?
Polydeoxyribonucleotides
1
2008
1
0.020
Why?
Models, Chemical
1
2008
34
0.020
Why?
Circular Dichroism
1
2008
30
0.020
Why?
Nucleic Acid Conformation
1
2008
48
0.020
Why?
Hematologic Diseases
1
2007
24
0.020
Why?
Infusions, Parenteral
1
2007
68
0.020
Why?
Sulfur Compounds
1
2006
7
0.020
Why?
Base Sequence
1
2007
257
0.020
Why?
Molecular Sequence Data
1
2007
359
0.020
Why?
Hydrogen Bonding
1
2006
23
0.020
Why?
Oxidation-Reduction
1
2006
268
0.020
Why?
Neoplasm Staging
1
2007
459
0.020
Why?
Poly(ADP-ribose) Polymerases
1
2004
9
0.010
Why?
Genes, p53
1
2004
23
0.010
Why?
Genes, ras
1
2004
25
0.010
Why?
Caspase 3
1
2004
31
0.010
Why?
Caspases
1
2004
42
0.010
Why?
Cloning, Molecular
1
2004
76
0.010
Why?
Cell Division
1
2004
98
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
163
0.010
Why?
Down-Regulation
1
2004
144
0.010
Why?
Up-Regulation
1
2004
196
0.010
Why?
Time Factors
1
2008
2181
0.010
Why?
Chemistry
1
2002
2
0.010
Why?
Chemical Phenomena
1
2002
3
0.010
Why?
Electrophoresis, Agar Gel
1
2002
13
0.010
Why?
Cattle
1
2002
101
0.010
Why?
Magnetic Resonance Spectroscopy
1
2002
82
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2004
262
0.010
Why?
Escherichia coli
1
2002
87
0.010
Why?
DNA Fragmentation
1
2002
8
0.010
Why?
Mutation
1
2004
503
0.010
Why?
Middle Aged
1
2007
11949
0.010
Why?
Kucera's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (185)
Explore
_
Co-Authors (18)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_